ANGELA CAIN: Open Payments
NPI 1003251612 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 25 payments from 6 companies in 2025. Trend: 2023 $226 · 2024 $417 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $212 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $96 |
| ABBVIE INC. | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, Jornay PM, HETLIOZ.
Industry payments across KY — which companies pay providers there.
